326 related articles for article (PubMed ID: 22139383)
21. Transduction of cytosine deaminase gene makes rat glioma cells highly sensitive to 5-fluorocytosine.
Ge K; Xu L; Zheng Z; Xu D; Sun L; Liu X
Int J Cancer; 1997 May; 71(4):675-9. PubMed ID: 9178825
[TBL] [Abstract][Full Text] [Related]
22. Targeted Treatment of Experimental Spinal Cord Glioma With Dual Gene-Engineered Human Neural Stem Cells.
Ropper AE; Zeng X; Haragopal H; Anderson JE; Aljuboori Z; Han I; Abd-El-Barr M; Lee HJ; Sidman RL; Snyder EY; Viapiano MS; Kim SU; Chi JH; Teng YD
Neurosurgery; 2016 Sep; 79(3):481-91. PubMed ID: 26671631
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic efficacy and safety of TRAIL-producing human adipose tissue-derived mesenchymal stem cells against experimental brainstem glioma.
Choi SA; Hwang SK; Wang KC; Cho BK; Phi JH; Lee JY; Jung HW; Lee DH; Kim SK
Neuro Oncol; 2011 Jan; 13(1):61-9. PubMed ID: 21062796
[TBL] [Abstract][Full Text] [Related]
24. Cytosine deaminase-producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model.
You MH; Kim WJ; Shim W; Lee SR; Lee G; Choi S; Kim DY; Kim YM; Kim H; Han SU
J Gastroenterol Hepatol; 2009 Aug; 24(8):1393-400. PubMed ID: 19486256
[TBL] [Abstract][Full Text] [Related]
25. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
[TBL] [Abstract][Full Text] [Related]
26. Mutation of Escherichia coli cytosine deaminase significantly enhances molecular chemotherapy of human glioma.
Kaliberov SA; Market JM; Gillespie GY; Krendelchtchikova V; Della Manna D; Sellers JC; Kaliberova LN; Black ME; Buchsbaum DJ
Gene Ther; 2007 Jul; 14(14):1111-9. PubMed ID: 17495948
[TBL] [Abstract][Full Text] [Related]
27. Antitumor efficiency of the cytosine deaminase/5-fluorocytosine suicide gene therapy system on malignant gliomas: an in vivo study.
Lv SQ; Zhang KB; Zhang EE; Gao FY; Yin CL; Huang CJ; He JQ; Yang H
Med Sci Monit; 2009 Jan; 15(1):BR13-20. PubMed ID: 19114960
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics and the bystander effect in CD::UPRT/5-FC bi-gene therapy of glioma.
Shi DZ; Hu WX; Li LX; Chen G; Wei D; Gu PY
Chin Med J (Engl); 2009 Jun; 122(11):1267-72. PubMed ID: 19567135
[TBL] [Abstract][Full Text] [Related]
29. The mixed human umbilical cord blood-derived mesenchymal stem cells show higher antitumor effect against C6 cells than the single in vitro.
Jiao H; Yang B; Guan F; Li J; Shan H; Song L; Hu X; Liang S; Du Y; Jiang C
Neurol Res; 2011 May; 33(4):405-14. PubMed ID: 21535940
[TBL] [Abstract][Full Text] [Related]
30. Isocytosine deaminase Vcz as a novel tool for the prodrug cancer therapy.
Kazlauskas A; Darinskas A; Meškys R; Tamašauskas A; Urbonavičius J
BMC Cancer; 2019 Mar; 19(1):197. PubMed ID: 30832616
[TBL] [Abstract][Full Text] [Related]
31. Umbilical cord-derived mesenchymal stromal/stem cells expressing IL-24 induce apoptosis in gliomas.
Fan S; Gao H; Ji W; Zhu F; Sun L; Liu Y; Zhang S; Xu Y; Yan Y; Gao Y
J Cell Physiol; 2020 Feb; 235(2):1769-1779. PubMed ID: 31301067
[TBL] [Abstract][Full Text] [Related]
32. Apoptosis induction with 5-fluorocytosine/cytosine deaminase gene therapy for human malignant glioma cells mediated by adenovirus.
Kurozumi K; Tamiya T; Ono Y; Otsuka S; Kambara H; Adachi Y; Ichikawa T; Hamada H; Ohmoto T
J Neurooncol; 2004 Jan; 66(1-2):117-27. PubMed ID: 15015777
[TBL] [Abstract][Full Text] [Related]
33. Lentiviral vector mediated modification of mesenchymal stem cells & enhanced survival in an in vitro model of ischaemia.
McGinley L; McMahon J; Strappe P; Barry F; Murphy M; O'Toole D; O'Brien T
Stem Cell Res Ther; 2011 Mar; 2(2):12. PubMed ID: 21385372
[TBL] [Abstract][Full Text] [Related]
34. Rat multipotent mesenchymal stromal cells lack long-distance tropism to 3 different rat glioma models.
Bexell D; Gunnarsson S; Svensson A; Tormin A; Henriques-Oliveira C; Siesjö P; Paul G; Salford LG; Scheding S; Bengzon J
Neurosurgery; 2012 Mar; 70(3):731-9. PubMed ID: 21869725
[TBL] [Abstract][Full Text] [Related]
35. [Mesenchymal stem cells expressing cytosine deaminase inhibit growth of murine melanoma B16F10 in vivo].
Krasikova LS; Karshieva SS; Cheglakov IB; Belyavsky AV
Mol Biol (Mosk); 2015; 49(6):1007-15. PubMed ID: 26710783
[TBL] [Abstract][Full Text] [Related]
36. In vivo efficacy and toxicity of 5-fluorocytosine/cytosine deaminase gene therapy for malignant gliomas mediated by adenovirus.
Ichikawa T; Tamiya T; Adachi Y; Ono Y; Matsumoto K; Furuta T; Yoshida Y; Hamada H; Ohmoto T
Cancer Gene Ther; 2000 Jan; 7(1):74-82. PubMed ID: 10678359
[TBL] [Abstract][Full Text] [Related]
37. The use of folate-PEG-grafted-hybranched-PEI nonviral vector for the inhibition of glioma growth in the rat.
Liang B; He ML; Chan CY; Chen YC; Li XP; Li Y; Zheng D; Lin MC; Kung HF; Shuai XT; Peng Y
Biomaterials; 2009 Aug; 30(23-24):4014-20. PubMed ID: 19427690
[TBL] [Abstract][Full Text] [Related]
38. Antitumor efficacy of VP22-CD/5-FC suicide gene system mediated by lentivirus in a murine uveal melanoma model.
Liu S; Song W; Liu F; Zhang J; Zhu S
Exp Eye Res; 2018 Jul; 172():144-151. PubMed ID: 29660328
[TBL] [Abstract][Full Text] [Related]
39. In vivo and in vitro glioma cell killing induced by an adenovirus expressing both cytosine deaminase and thymidine kinase and its association with interferon-alpha.
Wang ZH; Zagzag D; Zeng B; Kolodny EH
J Neuropathol Exp Neurol; 1999 Aug; 58(8):847-58. PubMed ID: 10446809
[TBL] [Abstract][Full Text] [Related]
40. Transplantation of prodrug-converting neural progenitor cells for brain tumor therapy.
Barresi V; Belluardo N; Sipione S; Mudò G; Cattaneo E; Condorelli DF
Cancer Gene Ther; 2003 May; 10(5):396-402. PubMed ID: 12719709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
